Insights Into Small Cell Lung Cancer (SCLC)

Perspectives on drivers in treatment decisions in the management of lung cancer

West – June 30, 2022

Faculty Chair

Keren Sturtz, MD

Intermountain McKay-Dee Hospital, Ogden, UT, USA

Central – July 11, 2022

Faculty Chair

Janakiraman Subramanian, MD, MPH

Inova Health System, Fairfax, VA, USA

Southeast – August 25, 2022

Faculty Chair

Ticiana Leal, MD

Winship Cancer Institute, Atlanta, GA, USA

More Information

  • Virtual series
  • California, Nevada, Oregon, Washington, Utah, Wyoming, Arizona, New Mexico

More Information

  • Virtual series
  • Kansas, Oklahoma, Texas, Missouri, Arkansas, Louisiana

More Information

  • Virtual series
  • Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee,  Virginia, West Virginia

Example Report

Start discovering the insights

View Report


  • A virtual, moderated roundtable discussion focusing on the treatment of small cell lung cancer
  • Disease state and data presentations were developed in conjunction with a national or regional oncology expert
  • Insights on the following therapies were obtained on the management of patients with SCLC and therapy strategies in second line and beyond


  • Data collection was accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors comprised 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.